Moneycontrol
HomeNewsTrendsHealthGovt asks syringe makers to put supplies on hold as demand for COVID-19 shots fall
Trending Topics

Govt asks syringe makers to put supplies on hold as demand for COVID-19 shots fall

Last year, the government was struggling to procure 90 crore syringes, mainly needed for the national COVID-19 vaccination drive following which the crucial medical supply was included in the list of goods restricted for export

February 17, 2022 / 18:18 IST
Story continues below Advertisement

Representational Image. Source: Reuters

The Centre has put the supply of syringes used in COVID-19 vaccination and shots for the Universal Immunisation Programme on hold for two months, throwing over 15 suppliers who have been affected, in a tizzy.

The directive, according to sources, is a result of surplus inventories, storage space crisis and a dwindling need for syringes and needles as demand for the COVID vaccination ebbs in the country

Story continues below Advertisement

Between July and October last year, the Health Ministry had placed orders for syringes, with an aim to target 2 billion COVID-19 vaccination shots by December 2021, which was later extended to March this year.

As the ministry was struggling to procure enough syringes, as per the required specifications, it had also put restrictions on the export of syringes—much to the discomfort of suppliers-- which was lifted only beginning this month.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show